(Q42921218)

English

Treatment of 161 Men with Symptomatic Late Onset Hypogonadism with Long-Acting Parenteral Testosterone Undecanoate: Effects on Body Composition, Lipids, and Psychosexual Complaints

scientific article published on August 30, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Treatment of 161 men with symptomatic late onset hypogonadism with long-acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaints (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Treatment of 161 Men with Symptomatic Late Onset Hypogonadism with Long-Acting Parenteral Testosterone Undecanoate: Effects on Body Composition, Lipids, and Psychosexual Complaints (English)

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Krisada Ratana-Olarn

3

object named as

Krisada Ratana-olarn

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

author name string

Sompol Permpongkosol

1

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Nakorn Tantirangsee

2

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Krisada Ratana-olarn

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20807330

4 July 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20807330

4 July 2024

publication date

30 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://api.elsevier.com/content/article/PII:S1743609515327612?httpAccept=text/xml

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

https://api.elsevier.com/content/article/PII:S1743609515327612?httpAccept=text/plain

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

https://academic.oup.com/jsm/article-pdf/7/11/3765/47359330/jsm_7_11_3765.pdf

Portable Document Format

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

https://academic.oup.com/jsm/article-pdf/7/11/3765/47359330/jsm_7_11_3765.pdf

Portable Document Format

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

The Journal of Sexual Medicine

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

3765-3774

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: longitudinal analyses of two geographically separate regional cohorts

1

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Low serum testosterone and mortality in older men.

2

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Low serum testosterone and estradiol predict mortality in elderly men.

3

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men?

4

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Metabolic complications of androgen deprivation therapy for prostate cancer

5

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism.

6

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.

7

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate

8

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone.

9

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

10

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations

11

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Blood testosterone threshold for androgen deficiency symptoms

12

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Association of specific symptoms and metabolic risks with serum testosterone in older men

13

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

14

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes?

15

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males

16

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Comparisons of waist circumferences measured at 4 sites

17

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Report from a Centers for Disease Control and Prevention Workshop on use of adult anthropometry for public health and primary health care

18

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Appropriate BMI for Asian populations

19

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

21

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease

22

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications.

23

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

The burden of testosterone deficiency syndrome in adult men: economic and quality-of-life impact

24

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Health-related quality of life instruments in studies of adult men with testosterone deficiency syndrome: a critical assessment

25

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

The prevalence of and risk factors for androgen deficiency in aging Taiwanese men.

26

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.

27

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function

28

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate.

29

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

30

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Aging Male Questionnaire in normal and complaining men.

31

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism

32

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Risk of late-onset hypogonadism (andropause) in Brazilian men over 50 years of age with osteoporosis: usefulness of screening questionnaires

33

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

A randomized, double-blind, placebo-controlled study of testosterone treatment in hypogonadal older men with subthreshold depression (dysthymia or minor depression).

35

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Effects of testosterone replacement in middle-aged men with dysthymia: a randomized, placebo-controlled clinical trial.

36

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Testosterone and depression: systematic review and meta-analysis

37

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Prostate size in hypogonadal men treated with a nonscrotal permeation-enhanced testosterone transdermal system

38

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials

39

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Impact of long-term testosterone treatment on plasma levels of free TFPI and TF-induced thrombin generation ex vivo in elderly men with low testosterone levels.

40

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Pharmacokinetics and safety of long-acting testosterone undecanoate injections in hypogonadal men: an 84-week phase III clinical trial

41

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome

43

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Impairment of couple relationship in male patients with sexual dysfunction is associated with overt hypogonadism.

44

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

The effects of treating male hypogonadism on couples' sexual desire and function

45

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Factors influencing time course of pain after depot oil intramuscular injection of testosterone undecanoate

46

1 reference

10.1111/J.1743-6109.2010.01994.X

https://api.crossref.org/works/10.1111/J.1743-6109.2010.01994.X

4 July 2024

Identifiers

10.1111/J.1743-6109.2010.01994.X

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42921218&oldid=2195103955"